ChiCTR2400084678 版本V1.0 版本创建时间2024/05/22 15:52:30 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400084678 

最近更新日期:

Date of Last Refreshed on:

2024-05-22 15:52:18 

注册时间:

Date of Registration:

2024-05-22 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

功能性磁刺激联合盆底肌肉训练对产后盆底功能障碍女性大脑血流动力学与脑功能连接的影响——随机对照试验

Public title:

Effects of functional magnetic stimulation combined with pelvic floor muscle training on cerebral hemodynamics and brain functional connectivity in women with postpartum pelvic floor dysfunction: a randomized controlled trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

功能性磁刺激联合盆底肌肉训练对产后盆底功能障碍女性大脑血流动力学与脑功能连接的影响——随机对照试验

Scientific title:

Effects of functional magnetic stimulation combined with pelvic floor muscle training on cerebral hemodynamics and brain functional connectivity in women with postpartum pelvic floor dysfunction: a randomized controlled trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

蔡丝妍 

研究负责人:

蔡丝妍 

Applicant:

Siyan Cai 

Study leader:

Siyan Cai 

申请注册联系人电话:

Applicant telephone:

+86 150 1518 6865

研究负责人电话:

Study leader's telephone:

+86 150 1518 6865

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

15015186865@163.com

研究负责人电子邮件:

Study leader's E-mail:

15015186865@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国江苏省苏州市工业园区崇文路9号

研究负责人通讯地址:

中国江苏省苏州市工业园区崇文路9号

Applicant address:

No.9 Chongwen Road, Suzhou Industrial Park, Jiangsu Province, China

Study leader's address:

No.9 Chongwen Road, Suzhou Industrial Park, Jiangsu Province, China

申请注册联系人邮政编码:

Applicant postcode:

215021

研究负责人邮政编码:

Study leader's postcode:

215021

申请人所在单位:

苏州大学附属第四医院(苏州市独墅湖医院)

Applicant's institution:

The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)

研究负责人所在单位:

苏州大学附属第四医院(苏州市独墅湖医院)

Affiliation of the Leader:

The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

240012

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

苏州大学附属第四医院(苏州市独墅湖医院)医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the Fourth Affiliated Hospital of Soochow University (Dushu Lake Hospital, Suzhou)

伦理委员会批准日期:

Date of approved by ethic committee:

2024-05-10 00:00:00

伦理委员会联系人:

沈林羽

Contact Name of the ethic committee:

Linyu Shen

伦理委员会联系地址:

中国江苏省苏州市工业园区崇文路9号

Contact Address of the ethic committee:

No.9 Chongwen Road, Suzhou Industrial Park, Jiangsu Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 150 0621 6120

伦理委员会联系人邮箱:

Contact email of the ethic committee:

sdhlunli@163.com

研究实施负责(组长)单位:

苏州大学附属第四医院(苏州市独墅湖医院)

Primary sponsor:

The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)

研究实施负责(组长)单位地址:

中国江苏省苏州市工业园区崇文路9号

Primary sponsor's address:

No.9 Chongwen Road, Suzhou Industrial Park, Jiangsu Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

苏州

Country:

China

Province:

Jiangsu

City:

Suzhou

单位(医院):

苏州大学附属第四医院(苏州市独墅湖医院)

具体地址:

中国江苏省苏州市工业园区崇文路9号

Institution
hospital:

The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)

Address:

No.9 Chongwen Road, Suzhou Industrial Park, Jiangsu Province, China

经费或物资来源:

国家级 - 国家重点研发计划 - 主动健康和老龄化科技应对(2022YFC2009700, 2022YFC2009706),校级/院级(苏州大学2020年度横向课题H201173)

Source(s) of funding:

National - National Key R&D Program - Active Health and Aging Science and Technology Response (2022YFC2009700, 2022YFC2009706), Horizontal project of Soochow University in 2020(H201173)

Target disease:

Pelvic floor dysfunction

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

盆底功能障碍(PFD)是产后妇女的常见疾病。盆底肌肉训练 (PFMT) 和功能性磁刺激(FMS)单独治疗盆底功能障碍(PFD)均有一定的效果。但联合治疗产后PFD的中枢和外周影响尚不清楚。本研究旨在从中枢和外周的层面比较 PFMT + FMS 与 PFMT + 假FMS 对产后PFD的有效性。  

Objectives of Study:

Pelvic floor dysfunction (PFD) is a common disorder in postpartum women. Pelvic floor muscle training (PFMT) and functional magnetic stimulation (FMS) are both effective in treating pelvic floor dysfunction (PFD) alone. However, the central and peripheral effects of combined treatment of postpartum PFD are unknown. This study aimed to compare the effectiveness of PFMT + FMS versus PFMT + sham FMS for postpartum PFD at the central and peripheral levels.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1: 经会阴四维超声诊断为盆底功能障碍的产后女性 2: 年龄20 ~ 40岁 3: 产后超过42天,无恶露排出

Inclusion criteria

1: postpartum PFD women diagnosed by transperineal four-dimensional ultrasound 2: aged 20 ~ 40 years 3: more than 42 days postpartum with no discharge

排除标准:

1: 阴道出血 2: 恶性肿瘤 3: 妊娠 4: 精神疾病 5: 认知障碍 6: 磁刺激禁忌症

Exclusion criteria:

1: vaginal bleeding 2: malignancy 3: pregnancy 4: psychiatric disorder 5: cognitive disorder

研究实施时间:

Study execute time:

From 2024-06-01 00:00:00 To 2024-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-01 00:00:00 To 2024-08-31 00:00:00  

干预措施:

Interventions:

组别:

假刺激组

样本量:

30

Group:

sham stimulation group

Sample size:

干预措施:

盆底肌肉训练+假功能性磁刺激

干预措施代码:

Intervention:

PFMT+ sham FMS

Intervention code:

组别:

真刺激组

样本量:

30

Group:

active stimulation group

Sample size:

干预措施:

盆底肌肉训练+功能性磁刺激

干预措施代码:

Intervention:

PFMT+ FMS

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

苏州 

Country:

China 

Province:

Jiangsu 

City:

Suzhou 

单位(医院):

苏州大学附属第四医院(苏州市独墅湖医院) 

单位级别:

三级 

Institution
hospital:

The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

Glazer 盆底表面肌电图(sEMG)

指标类型:

主要指标

Outcome:

Glazer pelvic floor sEMG

Type:

Primary indicator

测量时间点:

基线及治疗4周后

测量方法:

Measure time point of outcome:

Baseline and after 4 weeks of treatment

Measure method:

指标中文名:

经会阴四维超声

指标类型:

次要指标

Outcome:

transperineal 4-dimensional ultrasound

Type:

Secondary indicator

测量时间点:

基线及治疗4周后

测量方法:

Measure time point of outcome:

Baseline and after 4 weeks of treatment

Measure method:

指标中文名:

氧合血红蛋白(HbO2)

指标类型:

次要指标

Outcome:

Oxygenated hemoglobin (HbO2)

Type:

Secondary indicator

测量时间点:

基线及治疗4周后

测量方法:

Measure time point of outcome:

Baseline and after 4 weeks of treatment

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 40 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

主要研究者使用随机数字表法产生随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

The principal investigator used the random number table method to generate random sequences

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

双盲(对受试者和研究者均隐藏分组)

Blinding:

Double-blind (hidden groups for both subjects and investigators)

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

N/A

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF和Excel

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF and Excel

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-05-22 15:52:18